drugset / Trial / NCT02012608

Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy

NCT02012608

Phase 2 Terminated 14 enrolled University of Arkansas
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is a single-centered, double-blind, two-arm randomized study to determine if oral glutamine will reduce radiation toxicity for the subjects undergoing Breast Conserving Therapy.

Timeline

Start
2014-06
Primary completion
2019-04
Completion
2019-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glutamine Other / unclassified 10 g Oral

Indications